TABLE 2.
IEC type‡ | scn | chp | sak | sea | sep | ϕSa3 integrase | MES type† | IS1216V | tnp_tn551 | tnpR | ermB | aph(3′)-III | sat | aadE | cat | aacA-aphD |
C* | + | + | + | + | − | − | PM1 | + | + | + | + | + | + | + | + | − |
C** | + | + | + | − | − | − | PM9 | + | + | + | + | + | + | + | − | − |
C | + | + | − | − | − | − | PM18 | + | − | − | − | − | − | − | − | − |
B* | + | + | + | + | − | + | 6272-2 | + | + | + | + | + | − | − | + | + |
B** | + | + | + | − | + | + | unk-1 | + | + | + | + | + | + | − | + | − |
B | + | + | + | − | − | + | unk-2 | + | + | + | + | − | − | − | + | − |
G | + | − | + | − | + | + | unk-3 | + | + | + | + | − | − | − | + | + |
G** | + | − | + | − | − | + | unk-4 | − | + | − | + | + | − | − | + | + |
X | + | − | − | − | − | − | unk-5 | + | − | − | + | + | − | − | − | + |
unk-1 | − | + | − | − | − | − | unk-6 | − | + | − | + | − | − | − | + | − |
unk-7 | + | + | + | + | − | − | − | − | − | |||||||
unk-8 | + | + | + | + | − | − | − | − | + | |||||||
unk-9 | − | + | + | + | + | + | + | + | + |
scn, complement inhibitor; chp, chemotaxis-inhibiting protein; sak, Staphylokinase precursor; sea, staphylococcal enterotoxin A precursor; sep, staphylococcal enterotoxin P precursor; tnp tn551, tn551 transposase; tnpR, resolvase; ermB, erythromycin resistance transferase; aph(3′)-III, aminoglycoside 3′-phosphotransferase; sat, streptothricin acetyltransferase; aadE, streptomycin adenylyltransferase; cat, chloramphenicol acetyltransferase; aacA-aphD, bifunctional aminoglycoside modifying enzyme; ‡, as defined by Hung et al. (2016) and this study; †, as defined by Hung et al. (2012) and this study; * and **, IEC variants; +, positive for gene; −, negative for gene; unk, unknown.